These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


882 related items for PubMed ID: 19409967

  • 1. Edaravone attenuates white matter lesions through endothelial protection in a rat chronic hypoperfusion model.
    Ueno Y, Zhang N, Miyamoto N, Tanaka R, Hattori N, Urabe T.
    Neuroscience; 2009 Aug 18; 162(2):317-27. PubMed ID: 19409967
    [Abstract] [Full Text] [Related]

  • 2. Protective effects of catalpol on oligodendrocyte death and myelin breakdown in a rat model of chronic cerebral hypoperfusion.
    Cai QY, Chen XS, Zhan XL, Yao ZX.
    Neurosci Lett; 2011 Jun 15; 497(1):22-6. PubMed ID: 21524686
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of vascular nitric oxide after rat chronic brain hypoperfusion: spatial memory and immunocytochemical changes.
    de la Torre JC, Aliev G.
    J Cereb Blood Flow Metab; 2005 Jun 15; 25(6):663-72. PubMed ID: 15703700
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The free radical scavenger edaravone rescues rats from cerebral infarction by attenuating the release of high-mobility group box-1 in neuronal cells.
    Kikuchi K, Kawahara K, Tancharoen S, Matsuda F, Morimoto Y, Ito T, Biswas KK, Takenouchi K, Miura N, Oyama Y, Nawa Y, Arimura N, Iwata M, Tajima Y, Kuramoto T, Nakayama K, Shigemori M, Yoshida Y, Hashiguchi T, Maruyama I.
    J Pharmacol Exp Ther; 2009 Jun 15; 329(3):865-74. PubMed ID: 19293391
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Acute urinary retention and subsequent catheterization cause lipid peroxidation and oxidative DNA damage in the bladder: preventive effect of edaravone, a free-radical scavenger.
    Shimizu S, Saito M, Kinoshita Y, Kazuyama E, Tamamura M, Satoh I, Satoh K.
    BJU Int; 2009 Sep 15; 104(5):713-7. PubMed ID: 19338546
    [Abstract] [Full Text] [Related]

  • 10. Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain.
    Zhang N, Komine-Kobayashi M, Tanaka R, Liu M, Mizuno Y, Urabe T.
    Stroke; 2005 Oct 15; 36(10):2220-5. PubMed ID: 16166574
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Edaravone attenuates oxidative stress induced by chronic cerebral hypoperfusion injury: role of ERK/Nrf2/HO-1 signaling pathway.
    Zhang D, Xiao Y, Lv P, Teng Z, Dong Y, Qi Q, Liu Z.
    Neurol Res; 2018 Jan 15; 40(1):1-10. PubMed ID: 29125058
    [Abstract] [Full Text] [Related]

  • 13. A radical scavenger edaravone inhibits matrix metalloproteinase-9 upregulation and blood-brain barrier breakdown in a mouse model of prolonged cerebral hypoperfusion.
    Miyamoto N, Pham LD, Maki T, Liang AC, Arai K.
    Neurosci Lett; 2014 Jun 24; 573():40-45. PubMed ID: 24820542
    [Abstract] [Full Text] [Related]

  • 14. Edaravone, a free radical scavenger, protects against retinal damage in vitro and in vivo.
    Inokuchi Y, Imai S, Nakajima Y, Shimazawa M, Aihara M, Araie M, Hara H.
    J Pharmacol Exp Ther; 2009 May 24; 329(2):687-98. PubMed ID: 19201991
    [Abstract] [Full Text] [Related]

  • 15. Edaravone inhibits the expression of vascular endothelial growth factor in human astrocytes exposed to hypoxia.
    Ishikawa A, Yoshida H, Metoki N, Toki T, Imaizumi T, Matsumiya T, Yamashita K, Taima K, Satoh K.
    Neurosci Res; 2007 Dec 24; 59(4):406-12. PubMed ID: 17889387
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cilostazol protects against brain white matter damage and cognitive impairment in a rat model of chronic cerebral hypoperfusion.
    Watanabe T, Zhang N, Liu M, Tanaka R, Mizuno Y, Urabe T.
    Stroke; 2006 Jun 24; 37(6):1539-45. PubMed ID: 16645134
    [Abstract] [Full Text] [Related]

  • 19. Is endothelial dysfunction of cerebral small vessel responsible for white matter lesions after chronic cerebral hypoperfusion in rats?
    Huang Y, Zhang W, Lin L, Feng J, Chen F, Wei W, Zhao X, Guo W, Li J, Yin W, Li L.
    J Neurol Sci; 2010 Dec 15; 299(1-2):72-80. PubMed ID: 20850139
    [Abstract] [Full Text] [Related]

  • 20. The synergetic effect of edaravone and borneol in the rat model of ischemic stroke.
    Wu HY, Tang Y, Gao LY, Sun WX, Hua Y, Yang SB, Zhang ZP, Liao GY, Zhou QG, Luo CX, Zhu DY.
    Eur J Pharmacol; 2014 Oct 05; 740():522-31. PubMed ID: 24975100
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 45.